Search

everythinglearnresearchcommunity

for

Search:↓

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Indian herbal medicine shows promise for treating skin diseases but needs more research to prove effectiveness.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Black and Hispanic women are more likely to have alopecia areata than white women.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Muscles can make their own androgens, which may help muscle growth.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Finasteride 1 mg/day for five years effectively improves hair growth and slows hair loss in men with male pattern baldness, and is safe for long-term use.

Isotretinoin can cause serious birth defects and needs careful use, especially in pregnant women.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Topical immunotherapy is the best treatment for severe alopecia areata.

People with migraines often have mental health conditions, and treatment should be personalized to address both issues safely.

New therapies for alopecia areata show potential but need more research.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.